Key facts
- This page summarizes Shane Barton's Form 4 filing for PRECISION BIOSCIENCES INC (DTIL).
- 5 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 07 Mar 2022, 15:22.
Shane Barton - 26 Feb 2021 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)
- Reporting relationship
- VP & Corporate Controller
- Issuer ticker
- DTIL
- Reported as of
- 26 Feb 2021
- Net transaction value
- +$15,163
- SEC form
- 4
- Accepted by SEC
- 07 Mar 2022, 15:22:09 UTC
- Next SEC filing
- 09 Jun 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Dario Scimeca, Attorney-in-Fact for Shane Barton
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Shane Barton filed Form 4 for PRECISION BIOSCIENCES INC (DTIL) on 07 Mar 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: +$15,163.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DTIL
transaction
Common Stock
Award
- Transaction value
- $5,965
- Shares
- +1,294
- Change %
- Price
- $4.61
- Shares after
- 1,294
- Date
- 26 Feb 2021
- Ownership
- Direct
DTIL
transaction
Common Stock
Award
- Transaction value
- $6,451
- Shares
- +604
- Change %
- +47%
- Price
- $10.68
- Shares after
- 1,898
- Date
- 31 Aug 2021
- Ownership
- Direct
DTIL
transaction
Common Stock
Award
- Transaction value
- $2,747
- Shares
- +761
- Change %
- +40%
- Price
- $3.61
- Shares after
- 2,659
- Date
- 28 Feb 2022
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DTIL
transaction
Derivative
Employee Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +60,604
- Change %
- Price
- $0.000000
- Shares after
- 60,604
- Date
- 03 Mar 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 60,604
- Exercise price
- $4.08
- Footnotes
- F1
DTIL
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +38,161
- Change %
- Price
- $0.000000
- Shares after
- 38,161
- Date
- 03 Mar 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 38,161
- Exercise price
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The option vests as to 25% of the underlying shares on March 3, 2023 and thereafter in twelve substantially equal installments at the end of each three-month period over the 36 months following such date, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
Footnote F2
The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of the Company's Common Stock.
Footnote F3
The RSUs shall vest in three substantially equal annual installments on the anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.